Product overview
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog primarily used to reduce abdominal visceral fat and improve body fat distribution.
Benefits
Reduces abdominal visceral fat; improves lipid profiles; increases growth hormone levels; may help preserve muscle mass; improves overall body composition.
Usage Instructions
Typically administered once daily via subcutaneous injection, with a commonly referenced dose of 2 mg. A treatment period of 12–24 weeks may be considered under appropriate medical supervision. Specific dosage and treatment duration should be determined by a qualified healthcare professional.
Intended Audience
Individuals with excessive abdominal fat; individuals experiencing a weight-loss plateau; individuals seeking to improve overall body composition.
Benefits
Reduces abdominal visceral fat; improves lipid profiles; increases growth hormone levels; may help preserve muscle mass; improves overall body composition.
Usage Instructions
Typically administered once daily via subcutaneous injection, with a commonly referenced dose of 2 mg. A treatment period of 12–24 weeks may be considered under appropriate medical supervision. Specific dosage and treatment duration should be determined by a qualified healthcare professional.
Intended Audience
Individuals with excessive abdominal fat; individuals experiencing a weight-loss plateau; individuals seeking to improve overall body composition.